NASDAQ
BioMarin Pharmaceutical Inc. (BMRN) has a revenue compound annual growth rate of 11.60% over 5 years and 13.73% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.